Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.

BACKGROUND: Although leprosy is efficiently treated by multidrug therapy, resistance to first-line (dapsone, rifampin) and to second-line drugs (fluoroquinolones) was described worldwide. Since Mycobacterium leprae is not growing in vitro, phenotypic susceptibility testing requires a one year experi...

Full description

Bibliographic Details
Main Authors: Emmanuelle Cambau, Aurélie Chauffour-Nevejans, Liana Tejmar-Kolar, Masanori Matsuoka, Vincent Jarlier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3409109?pdf=render
_version_ 1818059866335346688
author Emmanuelle Cambau
Aurélie Chauffour-Nevejans
Liana Tejmar-Kolar
Masanori Matsuoka
Vincent Jarlier
author_facet Emmanuelle Cambau
Aurélie Chauffour-Nevejans
Liana Tejmar-Kolar
Masanori Matsuoka
Vincent Jarlier
author_sort Emmanuelle Cambau
collection DOAJ
description BACKGROUND: Although leprosy is efficiently treated by multidrug therapy, resistance to first-line (dapsone, rifampin) and to second-line drugs (fluoroquinolones) was described worldwide. Since Mycobacterium leprae is not growing in vitro, phenotypic susceptibility testing requires a one year experiment in the mouse model and this is rarely performed. Genetics on antibiotic resistance provide the basis for molecular tests able to detect for antibiotic resistance in leprosy. METHODOLOGY/PRINCIPAL FINDINGS: A reverse hybridization DNA strip test was developed as the GenoType LepraeDR test. It includes DNA probes for the wild-type sequence of regions of rpoB, gyrA and folP genes and probes for the prevalent mutations involved in acquired resistance to rifampin, fluoroquinolones and dapsone, respectively. The performances of the GenoType LepraeDR test were evaluated by comparing its results on 120 M. leprae strains, previously studied for resistance by the reference drug in vivo susceptibility method in the mouse footpad and for mutations in the gene regions described above by PCR-sequencing. The results of the test were 100% concordant with those of PCR sequencing and the mouse footpad test for the resistant strains: 16 strains resistant to rifampin, 22 to dapsone and 4 to ofloxacin with mutations (numbering system of the M. leprae genome) in rpoB (10 S456L, 1 S456F, 1 S456M + L458V, 1 H451Y, 1 G432S + H451D, 1 T433I + D441Y and 1 Q438V), in folP1 (8 P55L, 3 P55R, 7 T53I, 3 T53A, 1 T53V) and gyrA (4 A91V), respectively. Concordance was 98.3% for the susceptible strains, two strains showing a mutation at the codon 447 that in fact was not conferring resistance as shown by the in vivo method. CONCLUSIONS/SIGNIFICANCE: The GenoType LepraeDR test is a commercially available test that accurately detects for antibiotic resistance in leprosy cases. The test is easy to perform and could be implemented in endemic countries.
first_indexed 2024-12-10T13:23:20Z
format Article
id doaj.art-7c7dc267ad2a45fa82010f8bde6724dd
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-10T13:23:20Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-7c7dc267ad2a45fa82010f8bde6724dd2022-12-22T01:47:16ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352012-01-0167e173910.1371/journal.pntd.0001739Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.Emmanuelle CambauAurélie Chauffour-NevejansLiana Tejmar-KolarMasanori MatsuokaVincent JarlierBACKGROUND: Although leprosy is efficiently treated by multidrug therapy, resistance to first-line (dapsone, rifampin) and to second-line drugs (fluoroquinolones) was described worldwide. Since Mycobacterium leprae is not growing in vitro, phenotypic susceptibility testing requires a one year experiment in the mouse model and this is rarely performed. Genetics on antibiotic resistance provide the basis for molecular tests able to detect for antibiotic resistance in leprosy. METHODOLOGY/PRINCIPAL FINDINGS: A reverse hybridization DNA strip test was developed as the GenoType LepraeDR test. It includes DNA probes for the wild-type sequence of regions of rpoB, gyrA and folP genes and probes for the prevalent mutations involved in acquired resistance to rifampin, fluoroquinolones and dapsone, respectively. The performances of the GenoType LepraeDR test were evaluated by comparing its results on 120 M. leprae strains, previously studied for resistance by the reference drug in vivo susceptibility method in the mouse footpad and for mutations in the gene regions described above by PCR-sequencing. The results of the test were 100% concordant with those of PCR sequencing and the mouse footpad test for the resistant strains: 16 strains resistant to rifampin, 22 to dapsone and 4 to ofloxacin with mutations (numbering system of the M. leprae genome) in rpoB (10 S456L, 1 S456F, 1 S456M + L458V, 1 H451Y, 1 G432S + H451D, 1 T433I + D441Y and 1 Q438V), in folP1 (8 P55L, 3 P55R, 7 T53I, 3 T53A, 1 T53V) and gyrA (4 A91V), respectively. Concordance was 98.3% for the susceptible strains, two strains showing a mutation at the codon 447 that in fact was not conferring resistance as shown by the in vivo method. CONCLUSIONS/SIGNIFICANCE: The GenoType LepraeDR test is a commercially available test that accurately detects for antibiotic resistance in leprosy cases. The test is easy to perform and could be implemented in endemic countries.http://europepmc.org/articles/PMC3409109?pdf=render
spellingShingle Emmanuelle Cambau
Aurélie Chauffour-Nevejans
Liana Tejmar-Kolar
Masanori Matsuoka
Vincent Jarlier
Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
PLoS Neglected Tropical Diseases
title Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
title_full Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
title_fullStr Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
title_full_unstemmed Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
title_short Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
title_sort detection of antibiotic resistance in leprosy using genotype lepraedr a novel ready to use molecular test
url http://europepmc.org/articles/PMC3409109?pdf=render
work_keys_str_mv AT emmanuellecambau detectionofantibioticresistanceinleprosyusinggenotypelepraedranovelreadytousemoleculartest
AT aureliechauffournevejans detectionofantibioticresistanceinleprosyusinggenotypelepraedranovelreadytousemoleculartest
AT lianatejmarkolar detectionofantibioticresistanceinleprosyusinggenotypelepraedranovelreadytousemoleculartest
AT masanorimatsuoka detectionofantibioticresistanceinleprosyusinggenotypelepraedranovelreadytousemoleculartest
AT vincentjarlier detectionofantibioticresistanceinleprosyusinggenotypelepraedranovelreadytousemoleculartest